Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

UCB

Status: Completed

Conditions: Epilepsy

Treatments: Drug: Levetiracetam

Study type: Observational

Funder types: Industry

Identifiers

NCT00319605

N01242

Details and patient eligibility

About

Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.

Enrollment: 600 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study

Exclusion criteria

• Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study